Showing results (831-840 of 3,473) with videos related to
Sort By:
Pageof 348
Clinical Pharmacokinetics|April 22, 2025
Model-Informed Dose Optimization of Pazopanib in Real-World Patients with CancerZhiyuan Tan, Swantje Völler, Anyue Yin, et al.Clinical Pharmacokinetics|March 3, 2025
Ticagrelor is Associated with Increased Rosuvastatin Blood Concentrations in Patients who have had a Myocardial InfarctionTjaša Dermota, Borut Jug, Jurij Trontelj, et al.Clinical Pharmacokinetics|November 29, 2025
Design Optimization for Developing Population Pharmacokinetic Models in Critically Ill Children: Application to Teicoplanin, Piperacillin and MeropenemGastón García-Orueta, Laura Butragueño-Laiseca, María José Santiago, et al.Clinical Pharmacokinetics|May 4, 2024
Population Pharmacokinetics of Intravenous Lidocaine in Adults: A Systematic ReviewKeng Wah Foong, Sook Hui Chaw, Yoke Lin Lo, et al.Clinical Pharmacokinetics|November 9, 2004
Assessment of levothyroxine sodium bioavailability: recommendations for an improved methodology based on the pooled analysis of eight identically designed trials with 396 drug exposuresIngeborg Walter-Sack, Christof Clanget, Reinhard Ding, et al.Clinical Pharmacokinetics|July 7, 2026
Physiologically Based Pharmacokinetic (PBPK) Modeling of Antidepressants: A Scoping Review of Existing Models, Applications, and Software ToolsRebecca Leyla Huber, Oliver Scherf-ClavelClinical Pharmacokinetics|July 27, 2026
Population Pharmacokinetics of Bosutinib in Children with Philadelphia Chromosome-Positive Chronic Myelogenous Leukemia Based on a Phase I Dose-Finding Trial (ITCC-054/COG AAML1921) and Pediatric Recommended Phase II Dosage EvaluationJen-Hao Wu, Francisco Bautista, Erica Brivio, et al.Clinical Pharmacokinetics|August 21, 2026
Pharmacokinetics, Safety, and Dosing of Antiseizure Medications in Patients with Renal or Hepatic ImpairmentJingheng Wu, Miaomiao Li, Shuai WangClinical Pharmacokinetics|August 29, 2026
Protein Binding Determination of Cefepime, Flucloxacillin, Meropenem, Piperacillin and Tazobactam by Ultrafiltration in Critically Ill Patients: The Choice of Device MattersMatthieu Gregoire, Steven C Wallis, Paul G Williams, et al.Clinical Pharmacokinetics|August 12, 2003
Influence of sex on the pharmacokinetic interaction of fleroxacin and ciprofloxacin with caffeineMyo-Kyoung Kim, Charles Nightingale, David NicolauPageof 348